Galaxy Medical
The business, the turning points, and the decisions behind them.
Some sections are still being researched2 / 4
Sections to complete：02 · 05
01 / WHAT IT BUILT
What the company did
Galaxy Medical was a San Carlos, California medical-device company founded in 2020 developing pulsed electric field (PEF) ablation technology to treat cardiac arrhythmias. Its flagship CENTAURI system delivered high-voltage, high-frequency non-thermal energy bursts through focal catheters, with a proprietary WAVE1 waveform designed to reduce muscle stimulation and eliminate microbubbles that can cause strokes. The company raised $18 million in Series A financing from Apple Tree Partners in March 2021 and received CE Mark approval in August 2022.
02 / FAILURE REASONS
Material for this section is being gathered and checked. It will appear here once ready.
03 / EVENT HISTORY
Events in the structured record
- Founding
Galaxy Medical was founded in San Carlos, California to develop pulsed electric field ablation systems for cardiac arrhythmias.
- Series A
The company raised $18 million in Series A financing from Apple Tree Partners (ATP) in March 2021.
- CE Mark and acquisition
Galaxy Medical received CE Mark for its CENTAURI system in August 2022 and was acquired in a merger deal recorded on September 15, 2022.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN / AFTERMATH
Material for this section is being gathered and checked. It will appear here once ready.